CAMP CAMP4 Therapeutics Corporation

NASDAQ
$3.72

CAMP4 Therapeutics Corporation (CAMP) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.20 per share.

CAMP4 Therapeutics Beat Consensus Estimates
Thursday, November 5, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Nov 5
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.20)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $4.10

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About CAMP4 Therapeutics Corporation

CAMP4 is developing disease-modifying treatments for a broad range of genetic diseases where amplifying healthy protein may offer therapeutic benefits.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.